These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22495954)

  • 1. Why change injection sites for depot antipsychotic medication?
    Cox A; Emmerson B; Collyer B; Scott J
    Aust N Z J Psychiatry; 2012 Aug; 46(8):794. PubMed ID: 22495954
    [No Abstract]   [Full Text] [Related]  

  • 2. Injection of depot antipsychotic medications in patients with schizophrenia.
    Fleishman M
    J Clin Psychiatry; 2002 Sep; 63(9):840-1; author reply 841-2. PubMed ID: 12363128
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of two depot injection techniques.
    Mac Gabhann L
    Nurs Stand; 1998 Jun 3-9; 12(37):39-41. PubMed ID: 9732632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of depot injection techniques.
    Quartermaine S; Taylor R
    Nurs Times; 1995 Jul 26-Aug 1; 91(30):36-9. PubMed ID: 7644369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in nursing practice through a study comparing intramuscular depot injection administration techniques.
    MacGabhann L
    J Psychiatr Ment Health Nurs; 1997 Dec; 4(6):436-7. PubMed ID: 9505639
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting neuroleptics: technique for intramuscular injection.
    Bélanger-Annable MC
    Can Nurse; 1985 Sep; 81(8):41-3. PubMed ID: 2862986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Technics for intramuscular injections of delayed-action neuroleptics].
    Bélanger-Annable MC
    Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219
    [No Abstract]   [Full Text] [Related]  

  • 8. Postbasic nursing procedures. 1. Giving depot neuroleptic drugs.
    Nurs Mirror; 1982 Apr; 154(16):42-3. PubMed ID: 6123107
    [No Abstract]   [Full Text] [Related]  

  • 9. Why are Canadians complacent about long-acting injectable antipsychotic therapies? Come on, Canada, you can do better!
    Weiden PJ
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):3S-4S. PubMed ID: 23945066
    [No Abstract]   [Full Text] [Related]  

  • 10. Is depot medication safe in the setting of myopathy?
    Price JR; Bastiampillai T; Dhillon RS
    Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
    [No Abstract]   [Full Text] [Related]  

  • 11. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection technique. Depot drugs.
    Patterson C
    Nurs Times; 1998 Nov 25-Dec 1; 94(47):suppl 1-2. PubMed ID: 9934147
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical guideline recommendations for antipsychotic long-acting injections.
    Kane JM; Garcia-Ribera C
    Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Datapoints: depot antipsychotic use in New York State hospitals, 1994 to 2009.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2010 Jan; 61(1):9. PubMed ID: 20044411
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety.
    Hawley C; Turner M; Latif MA; Curtis V; Saleem PT; Wilton K
    Hum Psychopharmacol; 2010 Jan; 25(1):37-46. PubMed ID: 20041474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depot antipsychotics in the year 2011].
    Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE
    Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indiscriminate use of intramuscular injections: An unforeseen public health hazard.
    Kumar A; Garozzo D; Shukla DP
    Neurol India; 2019; 67(Supplement):S92-S93. PubMed ID: 30688240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.